Brief: Fresenius Medical Care Announces Beacon-Us, Generating Real-World Evidence Supporting High-Volume Hemodiafiltration For U.S. Dialysis Patients
BRIEF-Fresenius Medical Care Announces Beacon-Us, Generating Real-World Evidence Supporting High-Volume Hemodiafiltration For U.S. Dialysis Patients July 29 (Reuters) - Fresenius Medical Care AG FMEG.DE:
FRESENIUS MEDICAL CARE ANNOUNCES BEACON-US, GENERATING REAL-WORLD EVIDENCE SUPPORTING HIGH-VOLUME HEMODIAFILTRATION FOR U.S. DIALYSIS PATIENTS
Source text: ID:nPn6k10SCa
Further company coverage: FMEG.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed